By Mike Montemarano, Associate Editor04.29.22
Following introduction of the Dietary Supplement Listing Act, which seeks to establish a mandatory product listing (MPL) for dietary supplements sold in the U.S., Natural Products Association (NPA) president and CEO Daniel Fabricant, PhD, submitted a letter to the bill’s sponsors, Senators Dick Durbin (D-IL) and Mike Braun (R-IN).
Fabricant expressed the association’s opposition and “grave concerns” regarding the impact that MPL would have on the marketplace.
NPA directly opposes MPL, considering it “pre-market approval” that presents an undue burden on dietary supplement companies, as Fabricant said when FDA requested modernization to the Dietary Supplement Health and Education Act (DSHEA) in its FY2023 budget request.
NPA: MPL Will Not Benefit Reputable Companies
In NPA’s letter to Durbin and Braun, Fabricant, who served as director of the Division of Dietary Supplement Programs (now an Office at NIH) from 2011 to 2014, outlined a s
FREE SUBSCRIPTION
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
